Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill E Slansky

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Cancer Immunology Research|February 14, 2023
Low TCR Binding Strength Results in Increased Progenitor-like CD8+ Tumor-Infiltrating LymphocytesZachary L Z Hay, Jennifer R Knapp, Roman E Magallon, et al.
Annals of Surgical Oncology|August 6, 2003
Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastasesAjay Jain, Jill E Slansky, Laurel C Matey, et al.
The Journal of Biological Chemistry|October 10, 2013
Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptorJonathan D Buhrman, Kimberly R Jordan, Daniel J Munson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2016
Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer ModelKatherine A Waugh, Sonia M Leach, Brandon L Moore, et al.
Blood|October 31, 2002
Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimerasLeo Luznik, Jill E Slansky, Sanju Jalla, et al.
The Journal of Clinical Investigation|August 26, 2006
Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccinesRachel H McMahan, Jennifer A McWilliams, Kimberly R Jordan, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2012
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccinesKimberly R Jordan, Jonathan D Buhrman, Jonathan Sprague, et al.
Immunological Reviews|April 21, 2006
Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligandsFrances Crawford, Kimberly R Jordan, Brian Stadinski, et al.
Vaccine|March 11, 2008
Age-dependent tolerance to an endogenous tumor-associated antigenJennifer A McWilliams, Richard T Sullivan, Kimberly R Jordan, et al.
Lab on a Chip|February 27, 2026
Vector-free DNA transfection by nuclear envelope mechanoporationLeyla Akh, Apresio K Fajrial, Sunwoo Sohn, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Cancer Immunology Research|February 14, 2023
Low TCR Binding Strength Results in Increased Progenitor-like CD8+ Tumor-Infiltrating LymphocytesZachary L Z Hay, Jennifer R Knapp, Roman E Magallon, et al.
Annals of Surgical Oncology|August 6, 2003
Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastasesAjay Jain, Jill E Slansky, Laurel C Matey, et al.
The Journal of Biological Chemistry|October 10, 2013
Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptorJonathan D Buhrman, Kimberly R Jordan, Daniel J Munson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2016
Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer ModelKatherine A Waugh, Sonia M Leach, Brandon L Moore, et al.
Blood|October 31, 2002
Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimerasLeo Luznik, Jill E Slansky, Sanju Jalla, et al.
The Journal of Clinical Investigation|August 26, 2006
Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccinesRachel H McMahan, Jennifer A McWilliams, Kimberly R Jordan, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2012
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccinesKimberly R Jordan, Jonathan D Buhrman, Jonathan Sprague, et al.
Immunological Reviews|April 21, 2006
Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligandsFrances Crawford, Kimberly R Jordan, Brian Stadinski, et al.
Vaccine|March 11, 2008
Age-dependent tolerance to an endogenous tumor-associated antigenJennifer A McWilliams, Richard T Sullivan, Kimberly R Jordan, et al.
Lab on a Chip|February 27, 2026
Vector-free DNA transfection by nuclear envelope mechanoporationLeyla Akh, Apresio K Fajrial, Sunwoo Sohn, et al.
Pageof 6